Shares of Kimberly-Clark Corporation (KMB) fell roughly 3% on Wednesday after the company announced a series of executive changes connected to its pending acquisition of consumer health company Kenvue (KVUE). Kenvue shares also declined, dropping about 2% in the same session.

The leadership moves come as Kimberly-Clark works to finalize its purchase of Kenvue, a transaction expected to close in the fourth quarter of 2026. Once completed, the acquisition will bring the consumer health company under the Kimberly-Clark umbrella, and the executive changes map out who will run key parts of the combined organization. Under the transition plan, Chief Financial Officer Nelson Urdaneta and Chief Strategy Officer Jeff Melucci are assuming new integration oversight duties, while several Kenvue regional leaders are set to take over the North America and EMEA segments after closing. Because the deal has not yet closed, the reassignments serve as both a leadership announcement and a preview of how the combined company will be organized, while keeping the integration work assigned in the interim.

President and Chief Operating Officer Russell Torres informed the company on September 29 that he is leaving to take a chief executive role elsewhere. His final day is November 2, 2026. Torres joined Kimberly-Clark in 2020 and, in addition to his duties as president and COO, led the Integration Management Office handling the Kenvue transaction — making him the executive most directly tied to the deal's execution, and his exit the one change taking effect before the acquisition closes.

Integration Duties Redistributed

With Torres departing, two other executives are stepping into expanded roles. Jeff Melucci, the company's Chief Strategy, Business Development and Administrative Officer, will now oversee integration plans and programs. Chief Financial Officer Nelson Urdaneta will take charge of synergy delivery plans, which involves tracking the cost savings and efficiencies the merger is expected to produce. Splitting those responsibilities between the strategy and finance chiefs keeps both the program management and the savings-tracking sides of the integration covered as the closing window approaches.

Kimberly-Clark also laid out who will lead the combined company's regional operations once the deal closes, with the appointments drawing heavily from Kenvue's leadership bench.

New Regional Leadership

Carlos De Jesus, currently Kenvue's Group President for North America, will head the combined company's North America segment. John Carmichael, who holds that role at Kimberly-Clark, will leave shortly after the deal closes. De Jesus was already set to become Chief Growth Officer under earlier transition plans, and he will continue running the Global Growth Organization during the handover.

Leonardo Curado, Kenvue's Group President for Latin America, will move into the EMEA starting January 1, 2027. He had previously been named the future general manager for Latin America at the combined firm. Carlton Lawson, who currently leads EMEA at Kenvue, will step down at year-end. Anindya Dasgupta, who is set to become President of Enterprise Growth Markets, will take over direct oversight of Latin America.

Taken together, the regional handoffs follow a staged timeline: some changes take effect at closing in the fourth quarter of 2026, Lawson steps down at year-end, and Curado's move to EMEA follows on January 1, 2027 — a sequence of dates that frames what to watch as the transition progresses.

Market Snapshot

Wall Street continues to rate KMB a Buy overall, with a price target of $120 — well above where shares are currently trading following the drop. The stock's average trading volume sits around 3.88 million shares. While the longer-term analyst view remains positive, current technical signals point to a Sell rating. The two readings measure different things: analyst ratings and price targets are generally tied to fundamentals over a longer horizon, while technical ratings track shorter-term price and volume behavior. Kimberly-Clark carries a market capitalization of approximately $32.92 billion as of this week.

Kimberly-Clark manufactures tissue, paper, and personal care products, competing in categories where steady leadership matters for day-to-day operations. Once the acquisition closes, those businesses would sit alongside Kenvue's consumer health portfolio in a single corporate structure, with the newly named regional and integration executives responsible for running the combined footprint.

The Torres departure is the most immediate change. The remaining leadership moves will not take effect until the Kenvue acquisition actually closes later this year.

Source: CoinCentral (https://coincentral.com/kimberly-clark-kmb-stock-falls-3-after-executive-shakeup-ahead-of-kenvue-deal/)